Docs
All documentation Fundamental API Live (Delayed) API EOD Historical API Intraday API Real-Time (websockets) API Google Sheets add-on Excel add-on
Community
Academy 134 articles Forum Github 13 repos
Marketplace
Spreadsheets
Google Sheets add-on Excel add-on Wordpress plugin
Pricing
Overview Fundamentals API Earnings EOD API Sample Code Pricing
Register now
Free trial

No credit cards required

Get free API key
  1. Supported exchanges /
  2. NASDAQ /
  3. ONCO.NASDAQ

Onconetix Inc (ONCO NASDAQ) stock market data APIs

$0.164 -0.01(-5.8%) as of July 26, 2024
Price chart is built with Anychart

Onconetix, Inc., a biotechnology company, focuses on the research, development, and commercialization of solutions for men's health and oncology. It offers Entadfi, an FDA-approved, once daily pill that combines finasteride and tadalafil for the treatment of benign prostatic hyperplasia; and Proclarix, an in vitro protein-based blood diagnostic test for prostate cancer. The company was formerly known as Blue Water Biotech, Inc. and changed its name to Onconetix, Inc. in December 2023. Onconetix, Inc. was incorporated in 2018 and is headquartered in Cincinnati, Ohio.

Onconetix Inc Financial Data Overview

0.173
0.164
-
0.19
0.158
0.1-1.15
5 142 K
29 790 K
759 K
-0.502
3.67
Our easy-to-use no-coding solutions help you get the data effortlessly:
Excel Financial Add-In Google Sheets Financial Add-In Python
APIs SDK Windows Downloader

No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.

General: {
Code: 'ONCO',
Type: 'Common Stock',
Name: 'Onconetix Inc',
Exchange: 'NASDAQ',
CurrencyCode: 'USD',
CurrencyName: 'US Dollar',
CurrencySymbol: '$',
CountryName: 'USA',
CountryISO: 'US',
OpenFigi: 'BBG00PNSYQJ2',
ISIN: NULL,
CUSIP: '682160106',
CIK: '1782107',
EmployerIdNumber: NULL,
FiscalYearEnd: 'December',
IPODate: '2022-02-18',
InternationalDomestic: NULL,
Sector: 'Healthcare',
Industry: 'Biotechnology',
HomeCategory: 'Domestic',
IsDelisted: false,
}

Onconetix Inc Fundamental Data is available in our Financial Data APIs

  • Net Revenue 759 K
  • EBITDA -16 379 446
  • Earnings Per Share -2.51
  • Income Statements
  • Balance Sheets
  • Cash flows
Fundamental data package from $59.99 See full price
Get sample
of Fundamental API Data

Get Onconetix Inc Earnings via APIs

  • Latest Release 2024-05-20
  • EPS/Forecast -0.21

Get Onconetix Inc End-of-day Data via APIs

  • End of Day, Intraday and Live APIs
  • Splits
  • Dividends

Get Onconetix Inc latest news via APIs

Oncopeptides provides an update from the meeting with FDAs advisory committee ODAC

STOCKHOLM, Sept. 23, 2022 /PRNewswire/ -- Oncopeptides AB (publ) (Nasdaq: ONCO) (Stockholm: ONCO), a biotech company focused on research and development of therapies for difficult-to-treat hematologic...
  • ADULT PATIENTS
  • BIOTECH COMPANY
  • DEXAMETHASONE
  • DISEASE
  • FOOD AND DRUG ADMINISTRATION
  • HEMATOLOGICAL DISEASES
  • JAKOB LINDBERG
  • MONOCLONAL ANTIBODY
  • MULTIPLE MYELOMA
  • OCEAN
  • ODAC
  • ONCOLOGIC DRUGS ADVISORY COMMITTEE
  • PROTEASOME INHIBITOR
  • RESEARCH AND DEVELOPMENT
  • STOCKHOLM

Briefing Book for ODAC meeting on benefit/risk profile of Pepaxto now published

STOCKHOLM, Sept. 20, 2022 /PRNewswire/ -- Oncopeptides AB (publ) (NASDAQ: ONCO) (Stockholm: ONCO), a biotech company focused on research and development of therapies for difficult-to-treat hematologic...
  • AUTOLOGOUS STEM CELL TRANSPLANT
  • BIOTECH COMPANY
  • HEMATOLOGICAL DISEASES
  • ODAC
  • ONCO
  • ONCOLOGIC DRUGS ADVISORY COMMITTEE
  • ONCOPEPTIDES AB
  • RESEARCH AND DEVELOPMENT
  • STOCKHOLM
Do you have any questions?
support@eodhistoricaldata.com